Vertex Pharmaceuticals Earnings
NASDAQ: VRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$4.30
Vertex Pharmaceuticals earnings summary
Vertex Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $4.30. In its most recent report on Aug 4, 2026 (Q2 2026), VRTX posted EPS of $4.31. Revenue for the quarter was $3.33 billion.
Quarterly EPS is up 8.0% from the same quarter a year earlier. Across the last 16 reports, VRTX shares moved an average of 4.0% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
VRTX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $4.31 | — | +2.0% |
| May 5, 2026 | — | $4.02 | — | +1.7% |
| Feb 13, 2026 | — | $4.64 | — | -3.0% |
| Nov 4, 2025 | — | $4.20 | — | +6.8% |
| Aug 5, 2025 | — | $3.99 | — | +7.2% |
| May 6, 2025 | — | $2.49 | — | +3.2% |
| Feb 13, 2025 | — | $3.62 | — | +5.5% |
| Nov 5, 2024 | — | $4.01 | — | -9.9% |
| Aug 2, 2024 | — | $-13.92 | — | -5.3% |
| May 7, 2024 | — | $4.21 | — | +5.3% |
| Feb 15, 2024 | — | $3.71 | — | +1.9% |
| Nov 7, 2023 | — | $3.97 | — | -6.2% |
| Aug 2, 2023 | — | $3.52 | — | +2.8% |
| May 2, 2023 | — | $2.69 | — | -0.2% |
| Feb 10, 2023 | — | $3.14 | — | -1.3% |
| Oct 28, 2022 | — | $3.59 | — | -1.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.